AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion
AccessHope announces expansion of its executive leadership team with key appointments amid rapid growth. Dr. Yousuf Zafar, a Duke University oncologist and former Optum executive, joins as Chief Medical Officer. Peter Bridges, a veteran digital health leader, becomes Chief Strategy and Growth Officer, while Debra Morris is promoted to President.
The company, which delivers leading-edge cancer expertise, recently completed a spinout from City of Hope and secured $33 million in Series B funding. AccessHope has experienced double-digit annual growth since its founding and expanded its network of partnerships with NCI-Designated Comprehensive Cancer Centers, including prestigious institutions like Dana-Farber Cancer Institute and Johns Hopkins Medicine.
AccessHope annuncia l'espansione del suo team dirigenziale con nomine chiave in un periodo di rapida crescita. Il Dr. Yousuf Zafar, oncologo della Duke University e ex dirigente di Optum, si unisce come Chief Medical Officer. Peter Bridges, un leader esperto nella salute digitale, diventa Chief Strategy and Growth Officer, mentre Debra Morris viene promossa a Presidente.
L'azienda, che offre competenze all'avanguardia nel campo del cancro, ha recentemente completato un distacco da City of Hope e ha ottenuto 33 milioni di dollari in finanziamenti di Serie B. AccessHope ha registrato una crescita annuale a doppia cifra dalla sua fondazione ed ha ampliato la sua rete di partnership con i NCI-Designated Comprehensive Cancer Centers, inclusi istituti prestigiosi come il Dana-Farber Cancer Institute e la Johns Hopkins Medicine.
AccessHope anuncia la expansión de su equipo de liderazgo ejecutivo con nombramientos clave en medio de un rápido crecimiento. El Dr. Yousuf Zafar, oncólogo de la Universidad de Duke y exejecutivo de Optum, se une como Director Médico. Peter Bridges, un líder veterano en salud digital, se convierte en Director de Estrategia y Crecimiento, mientras que Debra Morris es promovida a Presidenta.
La empresa, que ofrece experiencia en cáncer de vanguardia, completó recientemente una separación de City of Hope y aseguró 33 millones de dólares en financiamiento de la Serie B. AccessHope ha experimentado un crecimiento anual de dos dígitos desde su fundación y ha ampliado su red de asociaciones con Centros de Cáncer Integrales Designados por el NCI, incluyendo instituciones de prestigio como el Dana-Farber Cancer Institute y Johns Hopkins Medicine.
AccessHope는 빠른 성장 속에서 주요 인사를 영입하며 경영진 리더십 팀의 확장을 발표했습니다. 유수프 자파 박사는 듀크 대학교의 종양학자이자 전 옵텀 임원으로서 최고 의료 책임자로 합류합니다. 피터 브리지가는 디지털 건강 분야의 베테랑 리더로서 최고 전략 및 성장 책임자가 되며, 데브라 모리스는 사장으로 승진했습니다.
이 회사는 최첨단 암 전문성을 제공하며, 최근 시티 오브 호프에서 분할되었고 3천3백만 달러의 시리즈 B 자금을 확보했습니다. AccessHope는 설립 이래 연평균 두 자릿수 성장을 경험했으며, Dana-Farber Cancer Institute와 Johns Hopkins Medicine과 같은 권위 있는 기관을 포함하여 NCI 지정 종합 암 센터와의 파트너십 네트워크를 확장했습니다.
AccessHope annonce l'expansion de son équipe de direction exécutive avec des nominations clés dans un contexte de croissance rapide. Le Dr Yousuf Zafar, oncologue à l'Université de Duke et ancien cadre d'Optum, rejoint en tant que directeur médical. Peter Bridges, un leader chevronné dans le domaine de la santé numérique, devient directeur de la stratégie et de la croissance, tandis que Debra Morris est promue présidente.
L'entreprise, qui offre une expertise en cancer à la pointe de la technologie, a récemment achevé une séparation de City of Hope et a sécurisé 33 millions de dollars lors d'un financement de série B. AccessHope a connu une croissance annuelle à deux chiffres depuis sa création et a élargi son réseau de partenariats avec des centres de cancer complets désignés par le NCI, y compris des établissements prestigieux tels que le Dana-Farber Cancer Institute et Johns Hopkins Medicine.
AccessHope gibt die Erweiterung seines Führungsteams mit wichtigen Ernennungen inmitten eines rasanten Wachstums bekannt. Dr. Yousuf Zafar, ein Onkologe der Duke University und ehemaliger Optum-Manager, tritt als Chief Medical Officer bei. Peter Bridges, ein erfahrener Führer im digitalen Gesundheitswesen, wird Chief Strategy and Growth Officer, während Debra Morris zur Präsidentin befördert wird.
Das Unternehmen, das führende Krebskenntnisse bereitstellt, hat kürzlich eine Abspaltung von City of Hope abgeschlossen und 33 Millionen Dollar in der Serie-B-Finanzierung gesichert. AccessHope hat seit seiner Gründung ein zweistelliges jährliches Wachstum erfahren und sein Netzwerk von Partnerschaften mit NCI-designierten umfassenden Krebszentren, einschließlich renommierter Institutionen wie dem Dana-Farber Cancer Institute und der Johns Hopkins Medicine, erweitert.
- Secured $33 million in Series B financing for product development and market expansion
- Experiencing double-digit annual growth since founding
- Expanded network partnerships with elite NCI-Designated Cancer Centers
- Successfully completed spinout to become standalone commercial business
- None.
- Duke University Oncologist and former Optum Executive Dr. Yousuf Zafar Named Chief Medical Officer
- Veteran Digital Health and Commercial Leader Peter Bridges to Serve as Chief Strategy and Growth Officer
- Debra Morris Promoted to President
"AccessHope has experienced phenomenal growth in 2024. More and more employers and payors are seeing the value of providing unique cancer benefits that bring cutting-edge expertise from top cancer institutions and subspecialists to the places and people who need it most. Our spring 2024 spinout from City of Hope to become a standalone commercial business, coupled with our recent Series B funding, have positioned us well for the future," said AccessHope Chief Executive Officer Brad Kreick. "We are excited to welcome Yousuf and Peter to the team, and promote Debby to her new role. I look forward to working with these seasoned executives as we respond to the growing demand to expand our products and services to further support patients and their families through their broader cancer journey."
New Additions to the C-Suite
- Dr. Yousuf Zafar, Chief Medical Officer – Dr. Zafar is a practicing oncologist, an adjunct professor at Duke University and a Fellow of the American Society of Clinical Oncology who has authored more than 100 publications. Most recently he was senior vice president of Medical Informatics at Optum and Change Healthcare, prior to its acquisition by Optum. In this role, he oversaw development and implementation of innovative solutions that leverage real-world evidence, precision medicine, digital health and data analytics to improve patient outcomes, optimize care delivery and reduce healthcare costs. Prior to Change Healthcare, Dr. Zafar was at the Duke Cancer Institute, where he served first as director of Healthcare Innovation, and then as chief quality and innovation officer. He earned an M.D. at The University of
Toledo College of Medicine and Life Sciences. He completed his oncology training and earned an M.H.S. in Health Sciences in Clinical Research from Duke University. As CMO, Dr. Zafar will lead AccessHope's clinical infrastructure. - Peter Bridges, Chief Strategy and Growth Officer – Bridges most recently was managing partner at Peter Bridges Partners, where he was a business strategy and commercial consultant to CEOs, Boards of Directors, investors and executive leadership teams at some of the world's top digital healthcare firms in
the United States ,Europe andAsia . Previously, he served as president of Curai Health, an AI/ML-enabled virtual primary care clinic. Prior to that, Bridges was chief commercial officer at Ginger (which merged with Headspace Health in 2021), where he led Ginger's Sales, Client Success, Channel, Health Plan, Strategic Partner and Consultant Relations teams. He currently serves on the advisory boards of MedHaul and Meru Health. Bridges holds B.A. degrees in economics and psychology from the University ofWisconsin -Madison and an M.B.A. in Finance from the Pepperdine Graziadio Business School. Bridges will lead AccessHope's corporate strategy and growth functions, as the company expands its capabilities across the broader oncology journey and enters new market segments. - Debra Morris, President – Morris joined AccessHope in May 2024. She previously was at Apria Healthcare, one of the nation's leading providers of integrated home healthcare equipment and services. She led the company through strategic transformation driven by significant changes in the home healthcare industry, including reimbursement, regulatory and technological changes, all culminating in Apria's 2021 IPO and subsequent acquisition by Owens and Minor. She currently serves on the boards of two public companies, Rexford Industrial Realty (NYSE: REXR), a leading industrial real estate firm, and Biote (Nasdaq: BTMD), an innovator of hormone replacement and therapeutic wellness. Morris will continue to oversee our operational functions with a focus on strategy implementation and business execution.
Expansion of the leadership team follows continued double-digital annual growth since AccessHope's founding. In the past year, the company accelerated its momentum, became a stand-alone commercial entity with Kreick at the helm, and closed on a
AccessHope also added to its network of partnerships with the country's most elite National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers, which now includes City of Hope, Dana-Farber Cancer Institute, Emory Healthcare and Winship Cancer Institute of Emory University, Fred Hutch Cancer Center, Johns Hopkins Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and UT Southwestern Medical Center and its Harold C. Simmons Comprehensive Cancer Center. Through its collaboration with these renowned cancer centers, AccessHope is able to provide people, no matter where they live, with access to expertise designed to improve their outcomes.
About AccessHope
AccessHope, LLC, believes in putting the ever-growing body of cancer knowledge to work for the greater good. The company delivers a revolutionary cancer benefit that is changing the way leading-edge expertise is delivered. Through collaborations with City of Hope, Dana-Farber Cancer Institute, Emory Healthcare and Winship Cancer Institute of Emory University, Fred Hutch Cancer Center, Johns Hopkins Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and UT Southwestern Medical Center and its Harold C. Simmons Comprehensive Cancer Center, AccessHope shares the latest discoveries in cancer care with employees' plans and local oncologists to help as they develop precise plans for treatment. The company brings the vast expertise of major medical centers to benefit people near and far. They never have to switch doctors. They never have to leave home. It's simply a better approach to treating cancer. An organization founded by City of Hope, AccessHope offers the benefit to approximately seven million members through more than 400 employers, including over 60 Fortune 500 companies. For more information about AccessHope, visit myaccesshope.org and follow us on LinkedIn and Twitter.
View original content to download multimedia:https://www.prnewswire.com/news-releases/accesshope-expands-executive-leadership-team-amid-rapid-growth-and-upcoming-market-expansion-302303703.html
SOURCE AccessHope
FAQ
What is the size of AccessHope's Series B funding round in 2024?
Who are the new executive appointments at AccessHope in 2024?
Which cancer centers are part of AccessHope's network partnership?
What is Debra Morris's role on Rexford Industrial Realty (REXR)?
